Cite
APA Citation
Jain, N., Roboz, G., Konopleva, M., Liu, H., Schiller, G., Jabbour, E., Desai, P., Whitfield, D., Haider, A., Zernovak, O., Frattini, M., Brownstein, C., & Larson, R. (n.d.). p1451: PRELIMINARY RESULTS FROM THE FLU/CY/ALEMTUZUMAB ARM OF THE PHASE I BALLI-01 TRIAL OF UCART22, AN ANTI-CD22 ALLOGENEIC CAR-T CELL PRODUCT, IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) CD22+ B-CELL ALL. HemaSphere, 6, 1333–1334. http://access.bl.uk/ark:/81055/vdc_100159756365.0x00000e